Godavari Drugs Ltd
GODAVARIGodavari Drugs Ltd
GODAVARI


Price Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
19.12 | 2.10 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
44.48 | 5.11 | 0.70% |
Forecast & Ratings
Detailed ForecastPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Godavari Drugs is engaged in the contract manufacturing, loan license manufacturing, manufacturing and supply of active pharmaceutical ingredients (APIs), drug intermediaries and fine chemicals
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 55.15 | 71.31 | 76.40 | 65.13 | 83.78 | 96.03 | 123.08 | 161.39 | 160.50 | 152.64 | ||||||||||
Raw Materials | 43.14 | 56.95 | 63.25 | 48.18 | 66.95 | 77.38 | 94.15 | 127.97 | 137.82 | 141.23 | ||||||||||
Power & Fuel Cost | 2.97 | 2.71 | 4.57 | 3.98 | 4.20 | 4.84 | 4.76 | 5.46 | 6.66 | |||||||||||
Employee Cost | 2.01 | 2.17 | 2.38 | 2.67 | 3.45 | 3.45 | 3.94 | 4.96 | 4.84 | |||||||||||
Selling & Administrative Expenses | 0.68 | 0.96 | 0.96 | 0.98 | 0.91 | 1.29 | 1.24 | 1.38 | 1.27 | |||||||||||
Operating & Other expenses | 0.26 | 3.84 | -0.78 | 4.60 | 2.56 | 2.70 | 8.74 | 10.04 | -0.88 | |||||||||||
EBITDA | 6.09 | 4.68 | 6.02 | 4.72 | 5.71 | 6.37 | 10.25 | 11.58 | 10.79 | 11.41 | ||||||||||
Depreciation/Amortization | 0.68 | 0.63 | 0.81 | 0.99 | 1.09 | 1.16 | 1.22 | 1.70 | 1.94 | 1.97 | ||||||||||
PBIT | 5.41 | 4.05 | 5.21 | 3.73 | 4.62 | 5.21 | 9.03 | 9.88 | 8.85 | 9.44 | ||||||||||
Interest & Other Items | 0.67 | 1.88 | 2.51 | 2.42 | 2.89 | 2.91 | 3.32 | 2.85 | 3.93 | 4.54 | ||||||||||
PBT | 4.74 | 2.17 | 2.70 | 1.31 | 1.73 | 2.30 | 5.71 | 7.03 | 4.92 | 4.90 | ||||||||||
Taxes & Other Items | 1.09 | 0.83 | 0.89 | 0.49 | 0.54 | 0.29 | 1.58 | 1.78 | 1.15 | 1.23 | ||||||||||
Net Income | 3.65 | 1.34 | 1.81 | 0.82 | 1.19 | 2.01 | 4.13 | 5.25 | 3.77 | 3.67 | ||||||||||
EPS | 4.85 | 1.78 | 2.40 | 1.09 | 1.58 | 2.67 | 5.48 | 6.97 | 5.01 | 4.87 | ||||||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Godavari Drugs Ltd | 18.62 | 2.10 | — |
Sun Pharmaceutical Industries Ltd | 35.09 | 5.01 | 0.93% |
Cipla Ltd | 35.23 | 4.16 | 0.69% |
Dr Reddy's Laboratories Ltd | 21.37 | 4.14 | 0.69% |
Price Comparison
Compare GODAVARI with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Increased Total Retail Holding
In last 3 months, retail holding in the company has increased by 1.46%
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
GODAVARI has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
News & Opinions
Godavari Drugs Standalone March 2022 Net Sales at Rs 44.28 crore, up 34.35% Y-o-Y
1 year ago•Moneycontrol
Godavari Drugs standalone net profit declines 1.55% in the March 2022 quarter
1 year ago•Business Standard
Godavari Drugs standalone net profit rises 67.06% in the June 2021 quarter
2 years ago•Business Standard
Godavari Drugs Standalone March 2021 Net Sales At Rs 32.96 Crore, Up 34.87% Y-o-Y
2 years ago•Moneycontrol
Godavari Drugs standalone net profit rises 69.74% in the March 2021 quarter
2 years ago•Business Standard
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 19.77%, vs industry avg of 8.45%
Increasing Market Share
Over the last 5 years, market share increased from 0.03% to 0.05%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 35.68%, vs industry avg of 9.82%